Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Dapagliflozin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Grignard coupling route for Dapagliflozin intermediate offers high purity and yield, reducing costs for pharmaceutical manufacturing.
Novel patent CN105622382B offers high-yield synthesis for Dapagliflozin intermediates with reduced waste and cost efficiency for global supply chains.
Novel patent CN117756611A offers efficient synthesis of dapagliflozin intermediate. Enhances supply chain reliability and reduces manufacturing complexity for pharmaceutical partners.
Patent CN114478454A reveals a convergent synthesis for SGLT2 inhibitors, offering significant cost reduction in API manufacturing and improved supply chain reliability.
Patent CN110922305A reveals a novel route for 5-bromo-2-chloro-4'-ethoxy diphenylmethane, eliminating ortho-impurities and ensuring high-purity API intermediates.
Novel one-pot method for (5-bromo-2-chlorophenyl)(4-ethoxyphenyl)methanone. High purity, reduced steps, eco-friendly process for API manufacturing.